NCT02869568

Brief Summary

Database of Institut Paoli-Calmettes patients diagnosed with ovarian cancer

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,000

participants targeted

Target at P75+ for all trials

Timeline
55mo left

Started Jan 2000

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Jan 2000Dec 2030

Study Start

First participant enrolled

January 1, 2000

Completed
16.6 years until next milestone

First Submitted

Initial submission to the registry

August 11, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 17, 2016

Completed
13.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2030

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2030

Last Updated

August 17, 2016

Status Verified

August 1, 2016

Enrollment Period

30 years

First QC Date

August 11, 2016

Last Update Submit

August 16, 2016

Conditions

Ovarian Neoplasms

Outcome Measures

Primary Outcomes (1)

  • Survival of patients

    Overall survival of all patients who come in the center

    10 years

Secondary Outcomes (1)

  • Collection of patients characteristics

    10 years

Study Arms (1)

Patients with ovarian cancer diagnosis

Other: Data collection

Interventions

Data collectionOTHER
Patients with ovarian cancer diagnosis

Eligibility Criteria

Age18 Years - 95 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with a diagnosis of ovarian Cancer

You may qualify if:

  • Patient with a diagnosis of ovarian cancer

You may not qualify if:

  • Diagnosis of fallopian tube cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut Paoli-Calmettes

Marseille, Bouches-du Rhône, 13009, France

RECRUITING

MeSH Terms

Conditions

Ovarian Neoplasms

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal Disorders

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Dominique Genre, MD

CONTACT

0033491223778drci.up@ipc.unicancer.fr

Lilian Laborde

CONTACT

0033491223778labordel@ipc.unicancer.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2016

First Posted

August 17, 2016

Study Start

January 1, 2000

Primary Completion (Estimated)

January 1, 2030

Study Completion (Estimated)

December 1, 2030

Last Updated

August 17, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)